Article Text

Download PDFPDF
Serum high-sensitive cardiac troponin for the risk assessment of cardiovascular events
  1. Tomoyuki Kawada
  1. Correspondence to Professor Tomoyuki Kawada, Department of Hygiene and Public Health, Nippon Medical School, Bunkyo-Ku, Tokyo 113-8602, Japan; kawada{at}nms.ac.jp

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

To the Editor I read with great interest the report of Everett.1 The author overviewed the meaning of serum high sensitivity cardiac troponin (hs-cTn) for the risk assessment of cardiovascular disease, presenting caution on clinical decision-making thresholds for screening. About hs-cTnT, past reports adopted cut-off point as …

View Full Text

Footnotes

  • Contributors TK has a responsibility for the content of the manuscript.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles